FilingSEC EDGAR10-K/A
Anavex Life Sciences Files 10-K/A Disclosing Material Weakness in Internal Controls
· SEC accepted
StageDisclosure
Filing content
Anavex Life Sciences filed an amended annual report disclosing a material weakness in internal control over financial reporting following the termination of its former CEO.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…